Market Place
Sourcing Support
BMS, Novartis, Gilead, Iovance Dinged In CBER Untitled Letters
30 Mar 2026 //
FIERCE PHARMA
Novartis Sued Over Third-Party Data Sharing From Branded Sites
25 Mar 2026 //
FIERCE PHARMA
FDA Issues Over 100 Warnings in Ad Crackdown
16 Sep 2025 //
RAPS
Aerovate`s stock plummets after sole product fails in PAH trial
18 Jun 2024 //
FIERCE PHARMA
Novartis hit with FDA letter over manufacturing of CAR-T Kymriah
07 Dec 2023 //
FIERCE PHARMA
Novartis Issues Voluntary US Nationwide Recall of Two Lots of Sandimmune
24 Nov 2023 //
PR NEWSWIRE
Novartis Issues Voluntary Recall of One Lot of Sandimmune Oral Solution
11 Sep 2023 //
PR NEWSWIRE
FDA finally schedules inspections for Novartis, Coherus drugs
22 Mar 2023 //
FIERCE PHARMA
Supreme Court rejects Novartis` request for stay in Gilenya patent battle
15 Oct 2022 //
ENDPTS
Novartis halts US production of 2 cancer drugs, citing quality
06 May 2022 //
FIERCEPHARMA
Novartis` Sandoz is recalling 13 drug lots on impurity concerns
25 Mar 2022 //
FIERCEPHARMA
Recall of Losacor Tablets and Losacor HCT Tablets
17 Sep 2021 //
GOV.HK
Novartis discontinues HCQ trial over enrollment challenges
22 Jun 2020 //
THEPENINSULAQUTAR
With ethics plan, Novartis CEO puts his money where his mouth is
14 Jan 2020 //
FIERCE PHARMA
NOVARTIS WITHDRAWS THE KYMRIAH® PATENT, A VICTORY ACHIEVED THROUGH
16 Dec 2019 //
MEDCINEDUMONDE
Health Canada says four more companies recalling versions of Zantac
27 Sep 2019 //
REUTERS
FDA Warns of Possible Interstitial Lung Disease, Pneumonitis,Breast Cancer Drugs
16 Sep 2019 //
CANCERTHERAPYADVISOR
Questions Pile up for Novartis as Senators Call on FDA to Take Action
13 Aug 2019 //
RAPS
Novartis recalls treatment over peanut contamination risk
15 May 2019 //
IN-PHARMATECHNOLOGIST
Aurobindo gets FDA thrashing at yet another sterile drug plant
10 Apr 2019 //
FIERCE PHARMA
Valsartan products not currently recalled - Updated November 27, 2018
28 Nov 2018 //
FDA
Novartis Calls for FDA Enforcement Against Biosimilar Misinformation
16 Nov 2018 //
RAPS
Sandoz recalls losartan products that contain impurity
12 Nov 2018 //
FIERCE PHARMA
Toxin at heart of drug recall shows holes in medical safety net
23 Aug 2018 //
REUTERS
Tainted valsartan has been on the market for 4 years, FDA discovers
09 Aug 2018 //
FIERCE PHARMA
Valsartan products not currently recalled - Updated August 8, 2018
09 Aug 2018 //
FDA
Tainted valsartan has been on the market for 4 years: FDA
07 Aug 2018 //
FIERCE PHARMA
Valsartan recall: 4 things patients should know
20 Jul 2018 //
CNN
Authorised products containing valsartan as active substance: Overview
16 Jul 2018 //
SWISSMEDIC
EU Recalls Some Valsartan Medicines Over Impurity
06 Jul 2018 //
RAPS
California court says Novartis & pharma can be sued over generic drug warnings
22 Dec 2017 //
STATNEWS
Novartis gets FDA breakthrough status for Tafinlar, Mekinist combination
24 Oct 2017 //
REUTERS
Intercept slides on FDA safety flag for Ocaliva
22 Sep 2017 //
FIERCE PHARMA
Midatech in-licenses Novartis’ panobinostat in brain cancers
07 Jun 2017 //
THE PHARMALETTER
DSM Sinochem licenses enzymatic antibiotic production tech Sandoz- sues Weiqida
16 Mar 2017 //
IN PHARMATECHNOLOGIST
Novartis products suspended in South Korea as officials weigh `tougher` report
02 Mar 2017 //
FIERCE PHARMA
Top pharma cos overcharging, NPPA lists 634 drugs for breaching price cap
27 Feb 2017 //
BUSINESS STANDARD
Pfizer hit with US FDA warning at Kansas generic Copaxone site
21 Feb 2017 //
IN PHARMATECHNOLOGIST
EMA raises manufacturing questions over Novartis biosimilar production
31 Jan 2017 //
FIERCE PHARMA
Hetero Labs plant hit with Form 483 for suspicious shredding of documents
26 Jan 2017 //
FIERCE PHARMA
Canada seeks Warnings on Prescription Painkillers Amid Rising Deaths
24 Jan 2017 //
REUTERS
Amgen Migraine Drug Winning the Race to Market
29 Sep 2016 //
PHARMAMANUFACTURING
Novartis intensifies Entresto push with new analysis
19 Sep 2016 //
REUTERS
Novartis Subsidiary Pays $16m to Settle Charges of Illegally Shipping Drugs
30 Aug 2016 //
RAPS
Novartis AG (NVS) Blasted for Blaming Management in Korea for Bribery Scandal
24 Aug 2016 //
BIOSPACE
Novartis Cements China Plans as $1 Billion Research Center Opens
03 Jun 2016 //
BLOOMBERG
BCR-ABL Tyrosine Kinase Inhibitors
04 May 2016 //
HEALTH CANADA
The FDA offers a controversial solution to the biosimilars name game
29 Aug 2015 //
FIERCE BIOTECH
FDA proposes adding suffixes to distinguish biosimilar drug names
27 Aug 2015 //
REUTERS
FDA to revise Novartis` Gilenya label to reflect brain infection risk
04 Aug 2015 //
REUTERS
Class action alleges pharma company’s patent infringement lawsuit was a ‘sham’
26 Jun 2015 //
LEGAL NEWSLINE
NICE says Novartis` Certican costs too much for NHS
07 Jun 2015 //
PHARMA TIMES
NICE recommends new licences for autoinflammatory disorders
29 May 2015 //
PHARMATIMES
Natco Brings its Scrappy Style to U.S. with Copaxone, Revlimid Knockoffs
09 Apr 2015 //
FIERCE PHARMA
Juno and Novartis settle CAR-T patent fight with little fanfare
07 Apr 2015 //
FIERCE BIOTECH
Teva takes another swing at generic Copaxone with new FDA petition
03 Apr 2015 //
FIERCE PHARMA
The Eyes Have It? Novartis is Accused of Interfering With Trials for Avastin
02 Apr 2015 //
PHARMALOT
